headache; gingivitis in gums; lot of pain, very severe on her mouth; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (headache), ORAL PAIN (lot of pain, very severe on her mouth) and GINGIVITIS (gingivitis in gums) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), THYROID, ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced ORAL PAIN (lot of pain, very severe on her mouth). On an unknown date, the patient experienced HEADACHE (headache) and GINGIVITIS (gingivitis in gums). The patient was treated with DIPHENHYDRAMINE HCL;LIDOCAINE;NYSTATIN for Adverse event, at an unspecified dose and frequency and AMOXICILLIN for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), ORAL PAIN (lot of pain, very severe on her mouth) and GINGIVITIS (gingivitis in gums) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to urgent care for the reported events.   Concomitant medications reported were Blood pressure pill, heart pills, stomach indigestion pills, and blood clots pills for drug use for unknown indication. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (headache), ORAL PAIN (lot of pain, very severe on her mouth) and GINGIVITIS (gingivitis in gums) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), THYROID, ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced ORAL PAIN (lot of pain, very severe on her mouth). On an unknown date, the patient experienced HEADACHE (headache) and GINGIVITIS (gingivitis in gums). The patient was treated with DIPHENHYDRAMINE HCL;LIDOCAINE;NYSTATIN for Adverse event, at an unspecified dose and frequency and AMOXICILLIN for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), ORAL PAIN (lot of pain, very severe on her mouth) and GINGIVITIS (gingivitis in gums) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to urgent care for the reported events.   Concomitant medications reported were Blood pressure pill, heart pills, stomach indigestion pills, and blood clots pills for drug use for unknown indication.